Differential susceptibility to extinction-induced despair and age-dependent alterations in the hypothalamic-pituitary-adrenal axis and neurochemical parameters

Neuropsychobiology

Volumn 58, Issue 3-4, 2008, Pages 138-153

  Topic, Bianca ^a   Oitzl, Melly S ^b   Meijer, Onno C ^b   Huston, Joseph P ^a   De Souza Silva, Maria A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Depression; Hormones; Learning; Memory; Neurochemistry; Operant extinction; Stress

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACETYLCHOLINE; CORTICOSTEROID RECEPTOR; DOPAMINE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; HOPELESSNESS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

3,4-DIHYDROXYPHENYLACETIC ACID; AGING; ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; DEPRESSION; DOPAMINE; EXTINCTION, PSYCHOLOGICAL; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MAZE LEARNING; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; REINFORCEMENT (PSYCHOLOGY); RNA, MESSENGER;

EID: 57649110865     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000182890     Document Type: Article

References (88)

1. Blazer DG: Depression in late life: review and commentary. J Gerontol Med Sci 2003;58:249-265.
2. Bonner D, Howard R: Treatment-resistant depression in the elderly. Int Psychogeriatr 1995;7(suppl):83-94.
3. Almeida OP, Burton EJ, Ferrier N, McKeith IG, O'Brien JT: Depression with late onset is associated with right frontal lobe atrophy. Psychol Med 2003;33:675-681.
4. Janssen J, Hulshoff Pol HE, de Leeuw FE, Schnack HG, Lampe IK, Kok RM, Kahn RS, Heeren TJ: Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. J Neural Neurosurg Psychiatry 2007;78:638-640.
5. Kumar A, Thomas A, Lavretsky H, Huda A, Curran J, Venkatraman T, Estanol L, Mintz J, Mega M, Toga A: Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 2002;159:630-636.
6. Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK, Krishnan KRR: Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005;62:537-544.
7. Manji HK, Drevets WC, Charney DS: The cellular neurobiology of depression. Nat Med 2001;7:541-547.
8. Nemeroff CB: Recent advances in the neurobiology of depression. Psychopharmacol Bull 2002;36(suppl 2):6-18.
9. Berton O, Nestler EJ: New approaches to antidepressant drug discovery: beyond monoamines. Nature Rev Neurosci 2006;7:137-151.
10. Millan MJ: The role of monoamines in the actions of established and 'novel' antidepressant agents: a critical review. Eur J Pharmacol 2004;500:371-384.
11. Holsboer F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23:477-501.
12. McEwen BS: Glucocorticoid-biogenic amine interactions in relation to mood and behaviour. Biochem Pharmacol 1987;36:1755-1763.
13. Dalm S, Enthoven L, Meijer OC, van der Mark MH, Karssen AM, de Kloet ER, Oitzl MS: Age-related changes in hypothalamicpituitary-adrenal axis activity of male C57BL/6J mice. Neuroendocrinology 2005;81:372-380.
14. Dere E, de Souza Silva MA, Topic B, Fiorillo C, Li JS, Sadile AG, Frisch C, Huston JP: Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav 2002;1:204-213.
15. Meijer OC, Topic B, Steenbergen PJ, Jocham G, Huston JP, Oitzl MS: Correlations between hypothalamus-pituitary-adrenal axis parameters depend on age and learning capacity. Endocrinology 2005;146:1372-1381.
16. Topic B, Willuhn I, Palomero-Gallagher N, Zilles K, Huston JP, Hasenöhrl RU: Impaired maze performance in aged rats is accompanied by increased density of NMDA, 5-HT1A, and alpha-adrenoceptor binding in hippocampus. Hippocampus 2007;17:68-77.
17. Workel JO, Oitzl MS, Fluttert M, Lesscher H, Karssen A, de Kloet ER: Differential and age-dependent effects of maternal deprivation on the hypothalamic-pituitary-adrenal axis of brown Norway rats from youth to senescence. J Neuroendocrinol 2001;13:569-580.
18. Schulz D, Topic B, de Souza Silva MA, Huston JP: Extinction-induced immobility in the water maze and its neurochemical concomitants in aged and adult rats: a possible model for depression? Neurobiol Learn Mem 2004;82:128-141.
19. Schulz D, Huston JP, Buddenberg T, Topic B: 'Despair' induced by extinction trials in the water maze: relationship with measures of anxiety in aged and adult rats. Neurobiol Learn Mem 2007;87:309-323.
20. Schulz D, Buddenberg T, Huston JP: Extinction-induced 'despair' in the water maze, exploratory behavior and fear: effects of chronic antidepressant treatment. Neurobiol Learn Mem 2007;87:624-634.
21. Porsolt RD, LePichon M, Jalfre M: Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-732.
22. Gesing A, Bilang-Bleuel A, Droste SK, Linthorst ACE, Holsboer F, Reul JM: Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J Neurosci 2001;21:4822-4829.
23. Linthorst ACE, Penalva RG, Flachskamm C, Holsboer F, Reul JM: Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotrophin releasing hormone receptor-dependent mechanism. Eur J Neurosci 2002;16:2441-2452.
24. Connor TJ, Kelly JP, Leonard BE: Forced swim test-induced neurochemical, endocrine, and immune changes in the rat. Pharmacol Biochem Behav 1997;58:961-967.
25. Brilman EI, Ormel J: Life events, difficulties and onset of depressive episodes in later life. Psychol Med 2001;31:859-869.
26. Adell A, Garcia-Marquez C, Armario A, Gelpi E: Chronic stress increases serotonin and noradrenaline in rat brain and sensitizes their responses to a further acute stress. J Neurochem 1988;50:1678-1681.
27. Overstreet DH, Steiner M: Genetic and environmental models of stress-induced depression in rats. Stress Med 1998;14:261-268.
28. Seligman ME: Learned helplessness. Annu Rev Med 1972;23:407-412.
29. Taghzouti K, Lamarque S, Kharouby M, Simon H: Interindividual differences in active and passive behaviors in the forced-swimming test: implications for animal models of psychopathology. Biol Psychiatry 1999;45:750-758.
30. Willner P: Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90-110.
31. Kawasaki K, Iwasaki T: Corticosterone secretion during extinction of runway response in rats. Life Sci 1997;61:1721-1728.
32. Topic B, Dere E, Schulz D, de Souza Silva MA, Jocham G, Kart E, Huston JP: Aged and adult rats compared in acquisition and extinction of escape from the water maze: focus on individual differences. Behav Neurosci 2005;119:127-144.
33. Thiel CM, Müller CP, Huston JP, Schwarting RKW:High versus low reactivity to a novel environment:behavioural, pharmacological and neurochemical assessments. Neurosci 1999;93:243-251.
34. Meijer OC, Steenbergen PJ, De Kloet ER: Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 2000;141:2192-2199.
35. Damsma G, Westerink BHC: A microdialysis and automated on-line analysis approach to study central cholinergic transmission in vivo; in Robinson TE, Justice JB (eds): Microdialysis in the Neurosciences. Amsterdam, Elsevier, 1991, pp 237-252.
36. Potter PE, Meek JL, Neff NH: Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J Neurochem 1983;41:188-194.
37. Krauth J: Nonparametric analysis of response curves. J Neurosci Methods 1980;2:239-252.
38. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998;19:269-301.
39. De Kloet ER, Joels M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005;6:463-475.
40. Palsson SP, Ostling S, Skoog I: The incidence of first-onset depression in a population followed from the age of 70 to 85. Psychol Med 2001;31:1159-1168.
41. Meltzer CC, Smith G, deKoksky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF 3rd: Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 1998;18:407-430.
42. Rowe JW, Kahn RL: Human aging: usual and successful. Science 1987;237:143-149.
43. Hasenöhrl RU, Soderstrom S, Mohammed AH, Ebendal T, Huston JP: Reciprocal changes in expression of mRNA for nerve growth factor and its receptors TrkA and LNGFR in brain of aged rats in relation to maze learning deficits. Exp Brain Res 1997;114:205-213.
44. Oitzl MS, Workel JO, Fluttert M, Frösch F, de Kloet ER: Maternal deprivation affects behaviour from youth to senescence: amplification of individual differences in spatial learning and memory in senescent brown Norway rats. Eur J Neurosci 2000;12:3771-3780.
45. Schulz D, Sergeeva OA, Ianovskii E, Luhmann HJ, Haas HL, Huston JP: Behavioural parameters in aged rats are related to LTP and gene expression of ChAT and NMDA-NR2 subunits in the striatum. Eur J Neurosci 2004;19:1373-1383.
46. Schulz D, Huston JP, Jezek K, Haas HL, Roth-Härer A, Selbach O, Luhmann HJ: Water maze performance, exploratory activity, inhibitory avoidance and hippocampal plasticity in aged superior and inferior learners. Eur J Neurosci 2002;16:2175-2185.
47. Schulz D, Huston JP: The sliding window correlation procedure for detecting hidden correlations: existence of behavioural subgroups illustrated with aged rats. J Neurosci Methods 2002;121:129-137.
48. Sykova E, Mazel T, Hasenöhrl RU, Harvey AR, Simonova Z, Mulders WH, Huston JP: Learning deficits in aged rats related to decrease in extracellular volume and loss of diffusion anisotropy in hippocampus. Hippocampus 2002;12:267-279.
49. Schweitzer I, Tuckwell V, O'Brien J, Ames D: Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry 2002;17:997-1005.
50. Zangen A, Overstreet DH, Yadid G: High serotonin and 5- hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 1997;69:2477-2483.
51. Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I, Zangen A: Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog Neurobiol 2000;62:353-378.
52. Veenema AH, Koolhaas JM, de Kloet ER: Basal and stress-induced differences in HPA axis, 5-HT responsiveness, and hippocampal cell proliferation in two mouse lines. Ann NY Acad Sci 2004;1018:255-265.
53. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M, Costentin J, Adrien J, Vaugeois JM: Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 2003;100:6227-6232.
54. Dunn AJ: Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone. J Neurochem 1988;51:406-412.
55. Berridge CW, Mitton E, Clark W, Roth RH: Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse 1999;32:187-197.
56. Gonzalez AM, Pazos A: Affinity changes in muscarinic acetylcholine receptors in the rat brain following acute immobilization stress: an autoradiographic study. Eur J Pharmacol 1992;214:261-268.
57. Gonzalez AM, Pazos A: Modification of muscarinic acetylcholine receptors in the rat brain following chronic immobilization stress: an autoradiographic study. Eur J Pharmacol 1992;223:25-31.
58. Heninger GR, Delgado PL, Charney DS: The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996;29:2-11.
59. Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965;122:509-522.
60. Slotkin TA, Seidler FJ, Ritchie JC: Regional differences in brain monoamine oxidase subtypes in an animal model of geriatric depression: effects of olfactory bulbectomy in young versus aged rats. Brain Res 2000;882:149-154.
61. Slotkin TA, Miller DB, Fumagalli F, McCook EC, Zhang J, Bissette G, Seidler FJ: Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J Pharmacol Exp Ther 1999;289:334-345.
62. Nestler EJ, Carlezon WA Jr: The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006;59:1151-1159.
63. Slotkin TA, Seidler FJ, Ritchie JC: Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res Bull 1998;47:345-348.
64. Nair NP, Ahmed SK, Kin NM, West TE: Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients. Acta Psychiatr Scand 1995;386(suppl):28-35.
65. Youdim MB, Bakhle YS: Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 2006;47(suppl 1):S287-S296.
66. Chan-Palay V, Asan E: Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 1989;287:373-392.
67. Fritze J: The adrenergic-cholinergic imbalance hypothesis of depression: a review and a perspective. Rev Neurosci 1993;4:63-93.
68. Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ: A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972;300:632-635.
69. Dilsaver SC: Cholinergic mechanisms in depression. Brain Res 1986;396:285-316.
70. Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV, Sanberg PR: Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 2002;7:525-535.
71. Helm KA, Han JS, Gallagher M: Effects of cholinergic lesions produced by infusions of 192 IgG-saporin on glucocorticoid receptor mRNA expression in hippocampus and medial prefrontal cortex of the rat. Neuroscience 2002;115:765-774.
72. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H: Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 2003;60:24-28.
73. DeRijk RH, Wüst S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER: A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006;91:5083-5089.
74. Meijer OC, van der Laan S, Lachize S, Steenbergen PJ, de Kloet ER: Steroid receptor coregulator diversity: what can it mean for the stressed brain? Neuroscience 2006;138:891-899.
75. Smith CL, O'Malley BW:Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004;25:45-71.
76. De Kloet ER, DeRijk R: Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance. Ann NY Acad Sci 2004;1032:14-34.
77. Apostolakis EM, Ramamurphy M, Zhou D, Onate S, O'Malley BW: Acute disruption of selected steroid receptor coactivators prevents reproductive behaviour in rats and unmasks genetic adaptation in knockout mice. Mol Endocrinol 2002;16:1511-1523.
78. Winnay JN, Xu J, O'Malley BW, Hammer GD:Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology 2006;147:1322-1332.
79. Bousios S, Karandrea D, Kittas C, Kitraki E: Effects of gender and stress on the regulation of steroid receptor coactivator-1 expression in the rat brain and pituitary. J Steroid Biochem Mol Biol 2001;78:401-407.
80. Hibberd C, Yau JL, Seckl JR: Glucocorticoids and the ageing hippocampus. J Anat 2000;4:553-562.
81. Means LW, Holsten RD: Individual aged rats are impaired on repeated reversal due to loss of different behavioral patterns. Physiol Behav 1992;52:959-963.
82. Tahera Y, Meltser I, Johansson P, Salman H, Canlon B: Sound conditioning protects hearing by activating the hypothalamic-pituitary-adrenal axis. Neurobiol Dis 2007;5:189-197.
83. Seckl JR, Yau JL, Holmes MC: Glucocorticoids, Serotonin and Their Interactions in the Hippocampus. Amsterdam, Harwood Academic, 1998.
84. Joels M, Van Riel E: Mineralocorticoid and glucocorticoid receptor-mediated effects on serotonergic transmission in health and disease. Ann NY Acad Sci 2004;1032:301-303.
85. Johansson IM, Bjartmar L, Marcusson J, Ross SB, Seckl JR, Olsson T: Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats. Brain Res Mol Brain Res 1998;62:92-95.
86. Yau JL, Hibberd C, Noble J, Seckl JR: The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. Brain Res Mol Brain Res 2002;106:117-123.
87. Uys JD, Muller CJ, Marais L, Harvey BH, Stein DJ, Daniels WM: Early life trauma decreases glucocorticoid receptors in rat dentate gyrus upon adult re-stress: reversal by escitalopram. Neuroscience 2006;137:619-625.
88. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT: Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005;30:225-242.